Investing in the age of longevity: Science panel

The Longevity Week: Master Investor Masterclass

It was the Longevity Forum’s Longevity Week this week and this Science Panel, supported by Master Investor, benchmarks current Longevity science, probes the progress of senolytic therapies, explores the grey areas between supplements and medicine and explores which areas of the Longevity space get the investment nod from the world of science.

On this panel:
James Lawford Davies, Partner at Hill Dickinson, who specialises in life sciences and health tech regulation and litigation;

Polina Mamoshina, Chief Scientist and Chief Operating Officer at Deep Longevity, the Hong Kong-based company that uses deep learning and bioinformatics to identify biomarkers of ageing;

Reason, a pillar of the Longevity scene, Co-founder at Repair Biotechnologies and editor of Fight_Aging.org;

Eric Verdin, CEO & President at Buck Institute for Research on Aging in San Francisco.

Phil Newman, CEO and founder First Longevity and Editor-in-Chief Longevity.Technology

The Longevity Week, 9-13 November 2020, is an initiative of The Longevity Forum. It brings together a diverse group of strategic partners of the Forum, supporters and participants whose goals are aligned with the mission of the Forum – to achieve longer, healthier and more fulfilled lives for as many people as possible. Our Investment Panel interview will be coming up on our website soon – stay tuned!
Check-out our weekly blog on Master Investor.

No spam - just the good stuff

Subscribe to our newsletter